Navigation Links
InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
Date:12/22/2008

International supplier of animal free, productivity enhancing cell culture media components offers its customers the chance to improve performance of cell culture development and bioproduction.

Fort Collins, CO (PRWEB) December 18, 2008 -- The 2008 Cell Engineering Conference, hosted by the Williamsburg BioProcessing Foundation, featured the products and supporting research data of InVitria, a company committed to delivering affordable, high-performing cell culture media components for bioproduction and regenerative medicine applications.

Over the course of the three day conference in Santa Barbara, CA, InVitria exhibited its Cellastim and Lacromin cell culture media component products to industry leaders seeking ways to improve their development timelines and optimize bioproduction.

InVitria's Director of Cell Culture, Dr. Steve Pettit, presented at the meeting and revealed data from a study entitled, "Recombinant Human Serum Albumin Expressed in Plants Improves the Productivity and Growth Kinetics of CHO." Tests have shown that Cellastim outperforms plasma-derived human serum albumin and can result in improved doubling time and an average 50% increase in productivity across a variety of chemically defined cell culture media.

"WilBio's Cell Engineering Conference was a great venue for InVitria to learn about the cell line development challenges facing the biopharmaceutical industry," said InVitria President Scott Deeter. "InVitria is dedicated to working with customers to improve cell line development speed by improving doubling time and expediting the development process without the use of serum or other animal components," Deeter said.

About InVitria
InVitria's Cellastim and Lacromin are animal free components used to enhance cell growth, reduce doubling times and optimize productivity in cell culture media. Cellastim and Lacromin are well-defined media components that improve performance for research, development and bioproduction.

For more information about InVitria's products, please contact us by e-mail or phone.

Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/WILBIO/INVITRIA/prweb1771634.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
2. Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
3. New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture
4. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
5. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
6. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
7. KGI Offers Mammalian Cell Culture Program for Biotech Industry Professionals
8. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
9. LGE Execs Teams with Texas Tech to License Advancements in Agriculture, Health and Life Sciences
10. Improved culture system for hepatitis C virus infection
11. Carbon hoofprint: Cows supplemented with rbST reduce agricultures environmental impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):